Feifei Yang
Impact in
- Pharmaceutical Science top 5%
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Histone Deacetylase Inhibitors Research 22
- Protein Degradation and Inhibitors 12
- Epigenetics and DNA Methylation 8
- Oncology 18
- Peptidase Inhibition and Analysis 8
- Co-authors
- Yihua Chen (12 shared papers)Na Zhao (7 shared papers)Di Ge (6 shared papers)William E. Friedrichs (1 shared paper)B H Bowman (1 shared paper)Mingyao Liu (9 shared papers)Zhengfang Yi (9 shared papers)Hua Zhang (13 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)European Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Gastroenterology (3 papers)Journal of Crohn s and Colitis (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Feifei Yang
75 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 115
- Pharmaceutical Science 89
- Cancer Research 188
- Molecular Biology 748
- Organic Chemistry 298
- Oncology 234
Countries citing papers authored by Feifei Yang
This map shows the geographic impact of Feifei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Yang more than expected).
Fields of papers citing papers by Feifei Yang
This network shows the impact of papers produced by Feifei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Yang. The network helps show where Feifei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 110 | |
| 2 | 2019 | 102 | |
| 3 | 2014 | 98 | |
| 4 | 2017 | 76 | |
| 5 | 2020 | 63 | |
| 6 | 2014 | 63 | |
| 7 | 2018 | 60 | |
| 8 | 2019 | 54 | |
| 9 | 2014 | 48 | |
| 10 | 2019 | 48 | |
| 11 | 2021 | 41 | |
| 12 | 2016 | 41 | |
| 13 | 2014 | 35 | |
| 14 | 2020 | 32 | |
| 15 | 2020 | 32 | |
| 16 | 2014 | 32 | |
| 17 | 2020 | 32 | |
| 18 | 2017 | 30 | |
| 19 | 2017 | 29 | |
| 20 | 2018 | 28 |
About Feifei Yang
Feifei Yang is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Epidemiology and Genetics, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (22 papers), Protein Degradation and Inhibitors (12 papers), Inflammatory Bowel Disease (9 papers), Epigenetics and DNA Methylation (8 papers), Peptidase Inhibition and Analysis (8 papers), Synthesis and biological activity (8 papers), Microscopic Colitis (7 papers) and Drug Solubulity and Delivery Systems (6 papers). The work is most often cited by research in Pharmaceutical Science (89 citations), Cancer Research (188 citations), Molecular Biology (748 citations), Organic Chemistry (298 citations) and Oncology (234 citations). Feifei Yang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yihua Chen, Na Zhao, Di Ge, William E. Friedrichs, B H Bowman, Mingyao Liu, Zhengfang Yi, Hua Zhang, Jingjie Li and Liying Ma. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Gastroenterology and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.